BioMab EGFR (Nimotuzumab Vials) 50mg/10ml

BioMab EGFR (Nimotuzumab) is a monoclonal antibody vial used in targeted cancer therapy. This 50mg/10ml formulation supports treatment protocols at controlled temperatures. Nimotuzumab is designed for specific therapeutic applications in oncology.

Strength

50mg/10ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Biocon Biologics India Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nimotuzumab, sold as BioMab EGFR, is primarily used in cancer treatment protocols targeting epidermal growth factor receptor (EGFR) pathways. It is employed in certain solid tumor therapies where EGFR overexpression plays a role. Patients and caregivers often ask what is nimotuzumab used for in cancer care.

Side Effects

As a monoclonal antibody, nimotuzumab works by binding to EGFR on cell surfaces, potentially slowing tumor growth. Users may experience effects related to the therapeutic mechanism rather than immediate symptom relief. Individual responses can vary based on treatment protocols.

Precautions & Warnings

Store BioMab EGFR vials at 2–8°C to maintain potency. Avoid freezing or exposure to higher temperatures. Handle vials carefully to prevent contamination. Consult healthcare providers before use if you have known allergies to biologics.

Avoid Interactions

Nimotuzumab may interact with other biologics or immunosuppressive therapies. Concurrent use with strong CYP inhibitors could affect metabolism. Discuss all medications with a healthcare provider to assess potential interactions. Alcohol use should be evaluated in the context of treatment.

References

Frequently Asked Questions

Nimotuzumab is used in certain cancer treatments targeting EGFR-positive tumors.

Store vials refrigerated between 2–8°C; do not freeze.

No, nimotuzumab is a monoclonal antibody used in targeted therapy.

Use with other therapies should be determined by a healthcare provider.

Side effects may include infusion reactions or skin-related effects; consult a doctor for details.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.